-
- 抗原 See all VEGF 抗体
- VEGF (Vascular Endothelial Growth Factor (VEGF))
-
抗原表位
- AA 27-233
-
适用
- 人, 犬
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This VEGF antibody is un-conjugated
-
应用范围
- Western Blotting (WB), Immunohistochemistry (IHC)
- 纯化方法
- Purified from mouse ascites fluids by affinity chromatography
- 免疫原
- Human recombinant protein fragment corresponding to amino acids 27-233 of human VEGFA (NP_003367) produced in E.coli.
- 克隆位点
- 4G3
- 亚型
- IgG2b
- Top Product
- Discover our top product VEGF Primary Antibody
-
-
- 应用备注
- WB 1:2500~5000, IHC: 1:50-1:150,
- 说明
-
The concentration of the product may vary between diferrent lots.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.5-1.0 mg/mL
- 缓冲液
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 44, Issue 4, pp. 1370-1380, (2018) (PubMed).
: "The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer." in: Journal of cellular and molecular medicine, Vol. 22, Issue 2, pp. 1257-1271, (2018) (PubMed).
: "
-
ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 44, Issue 4, pp. 1370-1380, (2018) (PubMed).
-
- 抗原
- VEGF (Vascular Endothelial Growth Factor (VEGF))
- 别名
- VEGF (VEGF 产品)
- 分子量
- 23.8 kDa
- 基因ID
- 7422
- NCBI登录号
- NM_001025366
- HGNC
- 7422
-